Home

Publications

Found 7 results

Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Balabaud, Charles  [Clear All Filters]
2012
Guichard, C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F et al..  2012.  Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genetics. Abstract
2011
Nault, JC, Fabre M, Couchy G, Pilati C, Jeannot E, Tran Van Nhieu J, Saint-Paul M-C, De Muret A, Redon M-J, Buffet C et al..  2011.  GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. Journal of Hepatology. Abstract
Urtasun, R, Latasa MU, Demartis MI, Balzani S, Goñi S, Garcia-Irigoyen O, Elizalde M, Azcona M, Pascale RM, Feo F et al..  2011.  Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation. Hepatology. 54(6):2149-2158. Abstract
2010
Villeneuve, J, Lepreux S, Mulot A, Bérard AM, Higa-Nishiyama A, Costet P, De Ledinghen V, Bioulac-Sage P, Balabaud C, Nurden AT et al..  2010.  A protective role for CD154 in hepatic steatosis in mice. Hepatology. :1969-1980. Abstract
2009
Haurie, V, Ménard L, Nicou A, Touriol C, Metzler P, Fernandez J, Taras D, Lestienne P, Balabaud C, Bioulac-Sage P et al..  2009.  Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism. Hepatology. 50:1871-1883. Abstract
Castillo, J, Goñi S, Latasa MU, Perugorría MJ, Calvo A, Muntané J, Bioulac–Sage P, Balabaud C, Prieto J, Avila MA.  2009.  Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform ΔEx2p73 in Human Hepatocellular Tumors. Gastroenterology. 137(5):1805-1815.e4. Abstract
Bioulac-Sage, P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc J-F, Cubel G, Trillaud H et al..  2009.  Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience. Hepatology. 50(2):481-489. Abstract